These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10728673)

  • 1. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
    Rogulski KR; Freytag SO; Zhang K; Gilbert JD; Paielli DL; Kim JH; Heise CC; Kirn DH
    Cancer Res; 2000 Mar; 60(5):1193-6. PubMed ID: 10728673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenografts.
    Geoerger B; Grill J; Opolon P; Morizet J; Aubert G; Terrier-Lacombe MJ; Bressac De-Paillerets B; Barrois M; Feunteun J; Kirn DH; Vassal G
    Cancer Res; 2002 Feb; 62(3):764-72. PubMed ID: 11830531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
    Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus.
    Habib NA; Mitry RR; Sarraf CE; Jiao LR; Havlík R; Nicholls J; Jensen SL
    Cancer Gene Ther; 2002 May; 9(5):414-20. PubMed ID: 11961664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.
    Heise C; Ganly I; Kim YT; Sampson-Johannes A; Brown R; Kirn D
    Gene Ther; 2000 Nov; 7(22):1925-9. PubMed ID: 11127580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
    Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
    Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
    You L; Yang CT; Jablons DM
    Cancer Res; 2000 Feb; 60(4):1009-13. PubMed ID: 10706117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis.
    Ganly I; Kim YT; Hann B; Balmain A; Brown R
    Gene Ther; 2001 Mar; 8(5):369-75. PubMed ID: 11313813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.
    Heise C; Lemmon M; Kirn D
    Clin Cancer Res; 2000 Dec; 6(12):4908-14. PubMed ID: 11156251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.
    McCormick F
    Semin Cancer Biol; 2000 Dec; 10(6):453-9. PubMed ID: 11170867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.
    Mulvihill S; Warren R; Venook A; Adler A; Randlev B; Heise C; Kirn D
    Gene Ther; 2001 Feb; 8(4):308-15. PubMed ID: 11313805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
    Steegenga WT; Riteco N; Bos JL
    Oncogene; 1999 Sep; 18(36):5032-43. PubMed ID: 10490840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
    Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
    Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT; You L; Uematsu K; Yeh CC; McCormick F; Jablons DM
    Cancer Res; 2001 Aug; 61(16):5959-63. PubMed ID: 11507034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
    Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
    Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient induction of cell death by adenoviruses requires binding of E1B55k and p53.
    Dix BR; O'Carroll SJ; Myers CJ; Edwards SJ; Braithwaite AW
    Cancer Res; 2000 May; 60(10):2666-72. PubMed ID: 10825139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells.
    Hu B; Joshua MN; Dong C; Qi Y
    J Virol Methods; 2004 May; 117(2):129-36. PubMed ID: 15041209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects.
    Heise CC; Williams A; Olesch J; Kirn DH
    Cancer Gene Ther; 1999; 6(6):499-504. PubMed ID: 10608346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.